Real-World Outcomes Among Crizotinib-Treated Patients with ROS1-Positive Advanced Non-Small-Cell Lung Cancer: A Community Oncology-Based Observational Study
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.